|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
16 December 2017 |
|
Main ID: |
NCT03203356 |
|
Date of registration:
|
26/05/2017 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Adrenal Function in GHD Children
|
|
Scientific title:
|
Evaluation of Adrenal Function Before and After GH Treatment in GHD Affected by GH Deficiency |
|
Date of first enrolment:
|
May 30, 2016 |
|
Target sample size:
|
30 |
|
Recruitment status: |
Completed |
|
URL:
|
https://clinicaltrials.gov/show/NCT03203356 |
|
Study type:
|
Observational |
|
Study design:
|
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
Italy
| | | | | | | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- prepubertal children with overt idiopathic growth hormone deficiency
Exclusion Criteria:
- Children with organic growth hormone deficiency or under treatment with
glucocorticoids
Age minimum:
5 Years
Age maximum:
12 Years
Gender:
All
|
|
Health Condition(s) or Problem(s) studied
|
|
Adrenal; Functional Disturbance
|
|
Growth Hormone Treatment
|
|
Intervention(s)
|
|
Drug: growth hormone
|
|
Primary Outcome(s)
|
|
Evaluation of adrenal function in GHD children at baseline and in control group
[Time Frame: baseline]
|
|
Change in adrenal function in GHD children during GH therapy
[Time Frame: 6 and 12 months]
|
|
Secondary ID(s)
|
|
UPalermo ITT-GHD
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|